Cell Reports (Mar 2023)

TGF-β in the microenvironment induces a physiologically occurring immune-suppressive senescent state

  • Satoru Matsuda,
  • Ajinkya Revandkar,
  • Taronish D. Dubash,
  • Arvind Ravi,
  • Ben S. Wittner,
  • Maoxuan Lin,
  • Robert Morris,
  • Risa Burr,
  • Hongshan Guo,
  • Karsen Seeger,
  • Annamaria Szabolcs,
  • Dante Che,
  • Linda Nieman,
  • Gad A. Getz,
  • David T. Ting,
  • Michael S. Lawrence,
  • Justin Gainor,
  • Daniel A. Haber,
  • Shyamala Maheswaran

Journal volume & issue
Vol. 42, no. 3
p. 112129

Abstract

Read online

Summary: TGF-β induces senescence in embryonic tissues. Whether TGF-β in the hypoxic tumor microenvironment (TME) induces senescence in cancer and how the ensuing senescence-associated secretory phenotype (SASP) remodels the cellular TME to influence immune checkpoint inhibitor (ICI) responses are unknown. We show that TGF-β induces a deeper senescent state under hypoxia than under normoxia; deep senescence correlates with the degree of E2F suppression and is marked by multinucleation, reduced reentry into proliferation, and a distinct 14-gene SASP. Suppressing TGF-β signaling in tumors in an immunocompetent mouse lung cancer model abrogates endogenous senescent cells and suppresses the 14-gene SASP and immune infiltration. Untreated human lung cancers with a high 14-gene SASP display immunosuppressive immune infiltration. In a lung cancer clinical trial of ICIs, elevated 14-gene SASP is associated with increased senescence, TGF-β and hypoxia signaling, and poor progression-free survival. Thus, TME-induced senescence may represent a naturally occurring state in cancer, contributing to an immune-suppressive phenotype associated with immune therapy resistance.

Keywords